Search Results - "Stępień, Henryk"

Refine Results
  1. 1

    High Expression of NEK2 and PIM1, but Not PIM3, Is Linked to an Aggressive Phenotype of Bronchopulmonary Neuroendocrine Neoplasms by Motylewska, Ewelina, Braun, Marcin, Stępień, Henryk

    Published in Endocrine pathology (01-09-2020)
    “…Dysregulations of the NEK2 and PIM1-3 kinase signaling axes have been implicated in the pathogenesis of several cancers, including those with a neuroendocrine…”
    Get full text
    Journal Article
  2. 2

    IGF1R and MAPK15 Emerge as Potential Targets of Pentabromobenzylisothioureas in Lung Neuroendocrine Neoplasms by Motylewska, Ewelina, Braun, Marcin, Kazimierczuk, Zygmunt, Ławnicka, Hanna, Stępień, Henryk

    Published in Pharmaceuticals (Basel, Switzerland) (29-10-2020)
    “…Pentabromobenzylisothioureas are antitumor agents with diverse properties, including the inhibition of MAPK15, IGF1R and PKD1 kinases. Their dysregulation has…”
    Get full text
    Journal Article
  3. 3

    Immunohistochemical detection of FSH receptors in pituitary adenomas and adrenal tumors by Pawlikowski, Marek, Pisarek, Hanna, Kubiak, Robert, Jaranowska, Maria, Stępień, Henryk

    Published in Folia histochemica et cytobiologica (08-10-2012)
    “…OBJECTIVESFollicle stimulating hormone (FSH) receptors (FSHR) are physiologically expressed in the ovary and testis. It is well known that FSHR are also…”
    Get full text
    Journal Article
  4. 4

    Elevated Concentrations of SERPINE2/Protease Nexin-1 and Secretory Leukocyte Protease Inhibitor in the Serum of Patients with Papillary Thyroid Cancer by Lawnicka, Hanna, Komorowski, Jan, Motylewska, Ewelina, Kuzdak, Krzysztof, Brożyna, Mateusz, Stępień, Tomasz, Stępień, Henryk

    Published in Disease markers (01-01-2017)
    “…Introduction. SERPINE2 and secretory leukocyte protease inhibitor (SLPI) are proteins with anticoagulant properties which could promote solid tumor growth…”
    Get full text
    Journal Article
  5. 5

    Alteration in the serum concentrations of FGF19, FGFR4 and βKlotho in patients with thyroid cancer by Motylewska, Ewelina, Stępień, Tomasz, Borkowska, Magdalena, Kuzdak, Krzysztof, Siejka, Agnieszka, Komorowski, Jan, Stępień, Henryk, Ławnicka, Hanna

    Published in Cytokine (Philadelphia, Pa.) (01-05-2018)
    “…•Serum concentration of FGF19 was increased in patients with thyroid cancer.•Serum concentration of βKlotho was decreased in patients with thyroid…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Decreased serum level of IL-7 in patients with active Graves’ disease by Motylewska, Ewelina, Nieć, Martyna, Siejka, Agnieszka, Komorowski, Jan, Ławnicka, Hanna, Świętosławski, Jacek, Stępień, Henryk

    Published in Cytokine (Philadelphia, Pa.) (01-10-2015)
    “…•Serum concentration of IL-7 was decreased in patients with active Graves’ disease.•IL-7 level in patients with Grave’s disease negatively correlated with FT4…”
    Get full text
    Journal Article
  8. 8

    Modulation of ghrelin axis influences the growth of colonic and prostatic cancer cells in vitro by Ławnicka, Hanna, Mełeń-Mucha, Gabriela, Motylewska, Ewelina, Mucha, Sławomir, Stępień, Henryk

    Published in Pharmacological reports (01-07-2012)
    “…The risk of different cancers seems to be associated with obesity. Moreover, low ghrelin levels observed in obese people may be implicated in cancer…”
    Get full text
    Journal Article
  9. 9

    Immunohistochemical detection of follicle stimulating hormone receptor (FSHR) in neuroendocrine tumours by Pawlikowski, Marek, Winczyk, Katarzyna, Stępień, Henryk

    Published in Endokrynologia Polska (01-01-2013)
    “…Follicle stimulating hormone receptors (FSHR) are well known to be expressed in gonads and in gonadal tumours. Recently,their incidence has also been revealed…”
    Get full text
    Journal Article
  10. 10

    Elevated serum concentrations of IGF-1 and IGF-1R in patients with thyroid cancers by Lawnicka, Hanna, Motylewska, Ewelina, Borkowska, Magdalena, Kuzdak, Krzysztof, Siejka, Agnieszka, Swietoslawski, Jacek, Stepien, Henryk, Stepien, Tomasz

    “…The rising incidence of thyroid cancer observed in the last few decades requires an improvement in diagnostic tools and management techniques for patients with…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Immunohistochemical detection of FSH receptors in pituitary adenomas and adrenal tumors by Pawlikowski, Marek, Pisarek, Hanna, Kubiak, Robert, Jaranowska, Maria, Stępień, Henryk

    Published in Folia histochemica et cytobiologica (01-01-2012)
    “…Follicle stimulating hormone (FSH) receptors (FSHR) are physiologically expressed in the ovary and testis. It is well known that FSHR are also expressed in…”
    Get full text
    Journal Article
  13. 13

    Concentration of angiopoietins 1 and 2 and their receptor Tie-2 in peripheral blood in patients with chronic obstructive pulmonary disease by Kierszniewska-Stępień, Dorota, Pietras, Tadeusz, Ciebiada, Maciej, Górski, Paweł, Stępień, Henryk

    Published in Postȩpy dermatologii i alergologii (01-12-2015)
    “…Both angiopoietins (angiopoietin 1 - Ang-1, angiopoietin 2 - Ang-2) and angiopoietin receptors (Tie) are involved in angiogenesis and vascular remodeling. To…”
    Get full text
    Journal Article
  14. 14

    Angiopoietin 1 (Ang-1), angiopoietin 2 (Ang-2) and Tie-2 (a receptor tyrosine kinase) concentrations in peripheral blood of patients with thyroid cancers by Niedźwiecki, Sebastian, Stępień, Tomasz, Kopeć, Krzysztof, Kuzdak, Krzysztof, Komorowski, Jan, Krupiński, Roman, Stępień, Henryk

    Published in Cytokine (Philadelphia, Pa.) (01-12-2006)
    “…There are limited and conflicting studies investigating the role of the angiopoietin family in human thyroid cancer development and progression. We have…”
    Get full text
    Journal Article
  15. 15

    Elevated peripheral blood plasma concentrations of tie-2 and angiopoietin 2 in patients with neuroendocrine tumors by Melen-Mucha, Gabriela, Niedziela, Agata, Mucha, Slawomir, Motylewska, Ewelina, Lawnicka, Hanna, Komorowski, Jan, Stepien, Henryk

    “…Gastro-entero-pancreatic/neuroendocrine (NET) tumors are highly vascularized neoplasms. However, our knowledge concerning circulating levels of the angiogenic…”
    Get full text
    Journal Article
  16. 16

    Effect of thalidomide affecting VEGF secretion, cell migration, adhesion and capillary tube formation of human endothelial EA.hy 926 cells by Komorowski, Jan, Jerczyńska, Hanna, Siejka, Agnieszka, Barańska, Patrycja, Ławnicka, Hanna, Pawłowska, Zofia, Stępień, Henryk

    Published in Life sciences (1973) (25-04-2006)
    “…Angiogenesis, new blood vessel formation, is a multistep process, precisely regulated by pro-angiogenic cytokines, which stimulate endothelial cells to…”
    Get full text
    Journal Article
  17. 17

    Serum levels of interleukin-1 receptor antagonist (IL-1ra) in thyroid cancer patients by Niedźwiecki, Sebastian, Stępień, Tomasz, Kuzdak, Krzysztof, Stępień, Henryk, Krupiński, Roman, Seehofer, Daniel, Rayes, Nada, Ulrich, Frank

    Published in Langenbeck's archives of surgery (01-05-2008)
    “…Background and aims There is growing evidence that cytokines and their antagonists are important in the pathogenesis of various malignancies. While there are…”
    Get full text
    Journal Article
  18. 18

    Effects of nitric oxide synthase inhibition on diethylstilbestrol-induced hyperprolactinaemia and pituitary tumourigenesis in rats by Pawlikowski, Marek, Pisarek, Hanna, Fryczak, Jolanta, Stępień, Henryk

    Published in Endokrynologia Polska (2012)
    “…The overexpression of nitric oxide synthase (NOS) has been found in tumours, including pituitary adenomas. It has also been found that NOS is overexpressed in…”
    Get full text
    Journal Article
  19. 19

    Inhibition of proliferation, VEGF secretion of human neuroendocrine tumor cell line NCI-H727 by an antagonist of growth hormone-releasing hormone (GH-RH) in vitro by Sacewicz, Małgorzata, Ławnicka, Hanna, Siejka, Agnieszka, Stępień, Tomasz, Krupiński, Roman, Komorowski, Jan, Stępień, Henryk

    Published in Cancer letters (08-09-2008)
    “…Abstract Growth hormone-releasing hormone (GH-RH) can stimulate not only growth hormone (GH) secretion by anterior pituitary gland but also proliferation of…”
    Get full text
    Journal Article
  20. 20